Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 10 studies | 45% ± 23% | |
epithelial cell | 9 studies | 34% ± 16% | |
ciliated cell | 7 studies | 26% ± 8% | |
oligodendrocyte | 7 studies | 29% ± 10% | |
retina horizontal cell | 6 studies | 43% ± 17% | |
GABAergic neuron | 5 studies | 33% ± 14% | |
basal cell | 5 studies | 24% ± 7% | |
granule cell | 4 studies | 60% ± 16% | |
interneuron | 4 studies | 28% ± 12% | |
secretory cell | 4 studies | 42% ± 9% | |
goblet cell | 4 studies | 29% ± 11% | |
pancreatic A cell | 3 studies | 28% ± 6% | |
endothelial cell | 3 studies | 31% ± 7% | |
fibroblast | 3 studies | 28% ± 8% | |
oligodendrocyte precursor cell | 3 studies | 28% ± 2% | |
type II pneumocyte | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 96% | 546.75 | 629 / 653 | 89% | 21.51 | 536 / 605 |
uterus | 89% | 523.55 | 152 / 170 | 93% | 40.00 | 428 / 459 |
bladder | 90% | 511.71 | 19 / 21 | 87% | 26.86 | 438 / 504 |
prostate | 93% | 686.04 | 228 / 245 | 83% | 17.44 | 419 / 502 |
ovary | 88% | 691.49 | 159 / 180 | 86% | 17.39 | 371 / 430 |
kidney | 92% | 672.94 | 82 / 89 | 80% | 14.79 | 717 / 901 |
stomach | 78% | 1123.50 | 279 / 359 | 92% | 34.23 | 264 / 286 |
brain | 98% | 3629.49 | 2580 / 2642 | 62% | 14.92 | 438 / 705 |
lung | 58% | 338.47 | 333 / 578 | 92% | 42.79 | 1066 / 1155 |
pancreas | 48% | 227.77 | 158 / 328 | 95% | 57.19 | 169 / 178 |
esophagus | 46% | 725.47 | 665 / 1445 | 97% | 49.32 | 177 / 183 |
intestine | 44% | 546.57 | 421 / 966 | 95% | 36.26 | 499 / 527 |
liver | 73% | 529.70 | 164 / 226 | 59% | 13.36 | 240 / 406 |
breast | 48% | 250.74 | 222 / 459 | 74% | 32.02 | 827 / 1118 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.69 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 98% | 34.43 | 44 / 45 |
skin | 93% | 949.85 | 1689 / 1809 | 4% | 0.61 | 19 / 472 |
heart | 87% | 1977.83 | 752 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 42% | 222.67 | 109 / 258 | 30% | 6.33 | 69 / 230 |
adipose | 35% | 178.16 | 426 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 31% | 119.71 | 416 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 16% | 187.86 | 144 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 13% | 1.53 | 10 / 80 |
lymph node | 0% | 0 | 0 / 0 | 10% | 1.85 | 3 / 29 |
spleen | 5% | 17.15 | 12 / 241 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.68 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030322 | Biological process | stabilization of membrane potential |
GO_0006813 | Biological process | potassium ion transport |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0035094 | Biological process | response to nicotine |
GO_0060075 | Biological process | regulation of resting membrane potential |
GO_0035725 | Biological process | sodium ion transmembrane transport |
GO_0031526 | Cellular component | brush border membrane |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0055037 | Cellular component | recycling endosome |
GO_0043204 | Cellular component | perikaryon |
GO_0097060 | Cellular component | synaptic membrane |
GO_0034705 | Cellular component | potassium channel complex |
GO_1902937 | Cellular component | inward rectifier potassium channel complex |
GO_0030425 | Cellular component | dendrite |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0005272 | Molecular function | sodium channel activity |
GO_0015271 | Molecular function | outward rectifier potassium channel activity |
GO_0005249 | Molecular function | voltage-gated potassium channel activity |
GO_0022841 | Molecular function | potassium ion leak channel activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005242 | Molecular function | inward rectifier potassium channel activity |
GO_0005267 | Molecular function | potassium channel activity |
GO_0005515 | Molecular function | protein binding |
Gene name | KCNK1 |
Protein name | Potassium channel subfamily K member 1 Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1) |
Synonyms | HOHO1 KCNO1 TWIK1 |
Description | FUNCTION: Ion channel that contributes to passive transmembrane potassium transport and to the regulation of the resting membrane potential in brain astrocytes, but also in kidney and in other tissues . Forms dimeric channels through which potassium ions pass in accordance with their electrochemical gradient. The channel is selective for K(+) ions at physiological potassium concentrations and at neutral pH, but becomes permeable to Na(+) at subphysiological K(+) levels and upon acidification of the extracellular medium . The homodimer has very low potassium channel activity, when expressed in heterologous systems, and can function as weakly inward rectifying potassium channel . Channel activity is modulated by activation of serotonin receptors (By similarity). Heterodimeric channels containing KCNK1 and KCNK2 have much higher activity, and may represent the predominant form in astrocytes (By similarity). Heterodimeric channels containing KCNK1 and KCNK3 or KCNK9 have much higher activity . Heterodimeric channels formed by KCNK1 and KCNK9 may contribute to halothane-sensitive currents . Mediates outward rectifying potassium currents in dentate gyrus granule cells and contributes to the regulation of their resting membrane potential (By similarity). Contributes to the regulation of action potential firing in dentate gyrus granule cells and down-regulates their intrinsic excitability (By similarity). In astrocytes, the heterodimer formed by KCNK1 and KCNK2 is required for rapid glutamate release in response to activation of G-protein coupled receptors, such as F2R and CNR1 (By similarity). Required for normal ion and water transport in the kidney (By similarity). Contributes to the regulation of the resting membrane potential of pancreatic beta cells (By similarity). The low channel activity of homodimeric KCNK1 may be due to sumoylation . The low channel activity may be due to rapid internalization from the cell membrane and retention in recycling endosomes . . |
Accessions | ENST00000446915.1 O00180 Q5T5E6 ENST00000366621.8 |